Biogen - 29 Year Stock Price History | BIIB

Historical daily share price chart and data for Biogen since 1991 adjusted for splits. The latest closing stock price for Biogen as of October 22, 2020 is 266.80.
  • The all-time high Biogen stock closing price was 475.98 on March 20, 2015.
  • The Biogen 52-week high stock price is 374.99, which is 40.6% above the current share price.
  • The Biogen 52-week low stock price is 257.60, which is 3.4% below the current share price.
  • The average Biogen stock price for the last 52 weeks is 293.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Biogen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 293.1471 294.2400 342.5500 258.6600 266.8000 -10.09%
2019 263.5519 304.6900 338.9600 216.7100 296.7300 -1.39%
2018 313.6443 334.1700 383.8300 257.5200 300.9200 -5.54%
2017 291.0549 291.7100 344.5800 246.5400 318.5700 12.34%
2016 280.1990 294.6200 330.1100 224.6000 283.5800 -7.43%
2015 352.5829 342.0100 475.9800 256.0400 306.3500 -9.75%
2014 317.9830 280.3300 360.6700 273.5175 339.4500 21.42%
2013 215.2810 150.0000 295.8800 142.8200 279.5720 91.00%
2012 136.5151 113.5000 156.0600 113.5000 146.3700 33.00%
2011 91.9759 67.2000 118.7200 65.0800 110.0500 64.13%
2010 56.3579 53.6400 68.2200 46.2200 67.0500 25.33%
2009 48.9437 48.4900 53.7000 42.1300 53.5000 12.32%
2008 55.4272 55.8700 71.3800 39.0200 47.6300 -16.32%
2007 56.5874 49.3300 82.5100 43.1300 56.9200 15.71%
2006 45.9898 46.7400 52.2600 40.7300 49.1900 8.64%
2005 43.2715 66.2900 67.8000 33.3500 45.2800 -32.02%
2004 57.2480 36.9400 67.9200 36.9400 66.6100 81.50%
2003 34.4312 34.3400 41.5700 28.0900 36.7000 10.64%
2002 47.4686 68.1500 70.9600 30.1500 33.1700 -51.88%
2001 56.9957 59.2500 74.5700 35.6900 68.9300 9.09%
2000 44.2699 31.0833 75.0833 19.1267 63.1867 92.94%
1999 14.0875 7.7917 32.7500 6.8550 32.7500 318.09%
1998 5.4740 5.6450 8.0200 2.9167 7.8333 36.71%
1997 4.6884 3.7500 7.6667 2.7083 5.7300 44.76%
1996 3.7283 3.1867 5.0200 2.4367 3.9583 21.79%
1995 1.1416 0.3950 3.8550 0.3750 3.2500 815.49%
1994 0.5854 0.9367 1.0833 0.3550 0.3550 -62.96%
1993 0.9571 1.5000 1.5000 0.6250 0.9583 -34.29%
1992 1.6281 2.1250 3.3333 1.0417 1.4583 -32.69%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $42.289B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.210B 10.56
Amgen (AMGN) United States $135.354B 14.70
CSL (CSLLY) Australia $97.716B 0.00
Gilead Sciences (GILD) United States $75.913B 10.93
Regeneron Pharmaceuticals (REGN) United States $61.349B 23.46
Vertex Pharmaceuticals (VRTX) United States $55.881B 31.18
Illumina (ILMN) United States $46.784B 54.40
Seattle Genetics (SGEN) United States $34.455B 0.00
Moderna (MRNA) United States $28.138B 0.00
BeiGene (BGNE) Cayman Islands $27.181B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.177B 11.32
Genmab (GMAB) Denmark $23.448B 14.79
Genmab (GNMSF) Denmark $22.360B 5.15
BioNTech SE (BNTX) Germany $21.348B 0.00
Immunomedics (IMMU) United States $20.276B 0.00
Incyte (INCY) United States $19.532B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.071B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.404B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
Exact Sciences (EXAS) United States $15.470B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.342B 35.90
BioMarin Pharmaceutical (BMRN) United States $14.129B 102.51
ARGENX SE-ADR (ARGX) Netherlands $12.342B 0.00
QIAGEN (QGEN) Netherlands $11.861B 30.10
MyoKardia (MYOK) United States $11.791B 0.00
Sarepta Therapeutics (SRPT) United States $10.795B 0.00
Bio-Techne Corp (TECH) United States $10.198B 69.97
Guardant Health (GH) United States $10.133B 0.00
Repligen (RGEN) United States $9.056B 143.74
Galapagos (GLPG) Belgium $8.611B 31.16
Mirati Therapeutics (MRTX) United States $8.420B 0.00
Ascendis Pharma (ASND) Denmark $8.244B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.487B 231.96
Exelixis (EXEL) United States $6.881B 25.02
Acceleron Pharma (XLRN) United States $6.713B 0.00
Adaptive Biotechnologies (ADPT) United States $6.549B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.498B 0.00
Novavax (NVAX) United States $6.027B 0.00
Blueprint Medicines (BPMC) United States $5.664B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.577B 15.24
Ultragenyx Pharmaceutical (RARE) United States $5.453B 0.00
Emergent Biosolutions (EBS) United States $5.118B 20.27
NeoGenomics (NEO) United States $4.721B 1425.00
Vir Biotechnology (VIR) United States $4.505B 0.00
Arena Pharmaceuticals (ARNA) United States $4.484B 0.00
China Biologic Products (CBPO) China $4.472B 26.55
Denali Therapeutics (DNLI) United States $4.397B 0.00
Amicus Therapeutics (FOLD) United States $4.393B 0.00
Fate Therapeutics (FATE) United States $4.185B 0.00
Halozyme Therapeutics (HALO) United States $4.141B 0.00
Twist Bioscience (TWST) United States $3.964B 0.00
Insmed (INSM) United States $3.908B 0.00
Reata Pharmaceuticals (RETA) United States $3.885B 0.00
Bluebird Bio (BLUE) United States $3.642B 0.00
Global Blood Therapeutics (GBT) United States $3.598B 0.00
MorphoSys AG (MOR) Germany $3.538B 46.36
Legend Biotech (LEGN) United States $3.514B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.346B 0.00
Eidos Therapeutics (EIDX) United States $2.826B 0.00
Alkermes (ALKS) Ireland $2.691B 56.40
PHARMA MAR SA (PHMMF) Spain $2.604B 0.00
Seres Therapeutics (MCRB) United States $2.410B 0.00
I-Mab (IMAB) China $2.318B 0.00
Sorrento Therapeutics (SRNE) United States $2.151B 0.00
Editas Medicine (EDIT) United States $2.066B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.012B 0.00
Zymeworks (ZYME) Canada $1.974B 0.00
Amarin (AMRN) Ireland $1.908B 0.00
Inovio Pharmaceuticals (INO) United States $1.843B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Northwest Biotherapeutics (NWBO) United States $1.817B 0.00
UniQure (QURE) Netherlands $1.737B 0.00
Viela Bio (VIE) United States $1.736B 0.00
Intra-Cellular Therapies (ITCI) United States $1.732B 0.00
Revance Therapeutics (RVNC) United States $1.652B 0.00
Zealand Pharma (ZEAL) Denmark $1.604B 0.00
Beam Therapeutics (BEAM) United States $1.580B 0.00
Sangamo Therapeutics (SGMO) United States $1.494B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Intellia Therapeutics (NTLA) United States $1.430B 0.00
Ligand Pharmaceuticals (LGND) United States $1.426B 48.22
Dicerna Pharmaceuticals (DRNA) United States $1.424B 0.00
Epizyme (EPZM) United States $1.397B 0.00
Mesoblast (MESO) Australia $1.393B 0.00
Arcus Biosciences (RCUS) United States $1.255B 0.00
Alcobra (ARCT) United States $1.226B 0.00
Coherus BioSciences (CHRS) United States $1.198B 6.98
Mersana Therapeutics (MRSN) United States $1.183B 0.00
Cytokineticsorporated (CYTK) United States $1.146B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.145B 0.00
NGM Biopharmaceuticals (NGM) United States $1.127B 0.00
Retrophin (RTRX) United States $1.061B 0.00
REGENXBIO (RGNX) United States $1.009B 0.00
Compugen (CGEN) Israel $1.004B 0.00
Myriad Genetics (MYGN) United States $1.003B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.002B 0.00
Genetron Holdings (GTH) China $0.996B 0.00
Heska (HSKA) United States $0.986B 0.00
Athenex (ATNX) United States $0.976B 0.00
Castle Biosciences (CSTL) United States $0.968B 0.00
Adverum Biotechnologies (ADVM) United States $0.941B 0.00
Vericel (VCEL) United States $0.938B 0.00
NantKwest (NK) United States $0.912B 0.00
Codexis (CDXS) United States $0.831B 0.00
Arvinas (ARVN) United States $0.823B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.820B 0.00
Intrexon (PGEN) United States $0.809B 0.00
Pliant Therapeutics (PLRX) United States $0.808B 0.00
Morphic Holding (MORF) United States $0.805B 0.00
Cellectis S.A (CLLS) France $0.768B 0.00
Agenus (AGEN) United States $0.759B 0.00
Alector (ALEC) United States $0.745B 0.00
Protagonist Therapeutics (PTGX) United States $0.741B 0.00
MiMedx (MDXG) United States $0.718B 0.00
AnaptysBio (ANAB) United States $0.704B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.701B 0.00
Cara Therapeutics (CARA) United States $0.697B 0.00
Frequency Therapeutics (FREQ) United States $0.695B 0.00
Pharming Group (PHGUF) Netherlands $0.692B 15.79
Sinovac Biotech (SVA) China $0.640B 43.13
Celldex Therapeutics (CLDX) United States $0.637B 0.00
Kadmon Holdings (KDMN) United States $0.635B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.630B 0.00
VBI Vaccines (VBIV) United States $0.603B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Geron (GERN) United States $0.574B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.562B 4.92
Cel-Sci (CVM) United States $0.532B 0.00
IVERIC Bio (ISEE) United States $0.527B 0.00
Albireo Pharma (ALBO) United States $0.523B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.520B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.520B 0.00
Anika Therapeutics (ANIK) United States $0.513B 22.44
Clovis Oncology (CLVS) United States $0.505B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.486B 0.00
MeiraGTx Holdings (MGTX) United States $0.483B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.471B 0.00
MannKind (MNKD) United States $0.461B 0.00
Avid Bioservices (CDMO) United States $0.459B 0.00
Dynavax Technologies (DVAX) United States $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.452B 0.00
Prothena (PRTA) Ireland $0.449B 0.00
Kala Pharmaceuticals (KALA) United States $0.437B 0.00
Sutro Biopharma (STRO) United States $0.433B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.433B 0.00
Amryt Pharma (AMYT) United Kingdom $0.433B 0.00
Starpharma Holdings (SPHRY) Australia $0.431B 0.00
Cue Biopharma (CUE) United States $0.417B 0.00
Scholar Rock Holding (SRRK) United States $0.411B 0.00
Forte Biosciences (FBRX) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.382B 0.00
Kamada (KMDA) Israel $0.377B 18.00
Puma Biotechnology (PBYI) United States $0.375B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.374B 0.00
Trevena (TRVN) United States $0.366B 0.00
Syros Pharmaceuticals (SYRS) United States $0.360B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
IBio (IBIO) United States $0.352B 0.00
ANI Pharmaceuticals (ANIP) United States $0.344B 8.13
Spero Therapeutics (SPRO) United States $0.344B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.342B 0.00
BioDelivery Sciences (BDSI) United States $0.334B 23.64
AC Immune SA (ACIU) Switzerland $0.334B 0.00
Precision BioSciences (DTIL) United States $0.333B 0.00
Athersys (ATHX) United States $0.322B 0.00
NextCure (NXTC) United States $0.317B 0.00
Cardiff Oncology (CRDF) United States $0.316B 0.00
Innate Pharma S.A (IPHA) France $0.315B 0.00
CytomX Therapeutics (CTMX) United States $0.310B 0.00
ChromaDex (CDXC) United States $0.304B 0.00
WAVE Life Sciences (WVE) Singapore $0.302B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.301B 0.00
Pluristem Therapeutics (PSTI) Israel $0.274B 0.00
Affimed (AFMD) Germany $0.258B 0.00
PDL BioPharma (PDLI) United States $0.252B 0.00
Selecta Biosciences (SELB) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.233B 0.00
Arbutus Biopharma (ABUS) United States $0.233B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
XOMA (XOMA) United States $0.219B 0.00
Verastem (VSTM) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Five Prime Therapeutics (FPRX) United States $0.208B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Dyadic (DYAI) United States $0.192B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.192B 0.00
Eton Pharmaceuticals (ETON) United States $0.191B 0.00
ADMA Biologics Inc (ADMA) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
CorMedix Inc (CRMD) United States $0.179B 0.00
Cerecor (CERC) United States $0.178B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.174B 0.00
DBV Technologies S.A (DBVT) France $0.174B 0.00
Biofrontera AG (BFRA) Germany $0.170B 0.00
GENFIT S.A (GNFT) France $0.167B 0.00
Theratechnologies (THTX) Canada $0.166B 0.00
Kindred Biosciences (KIN) United States $0.163B 0.00
Liquidia Technologies (LQDA) United States $0.157B 0.00
Exicure (XCUR) United States $0.155B 0.00
VolitionRX (VNRX) United States $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.150B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Prometic Life Sciences (LMNL) Canada $0.149B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.148B 6.90
Checkpoint Therapeutics (CKPT) United States $0.147B 0.00
Bellus Health (BLU) Canada $0.145B 0.00
SESEN BIO, INC (SESN) United States $0.138B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
AquaBounty Technologies (AQB) United States $0.133B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
Aytu Bioscience (AYTU) United States $0.127B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.122B 0.00
Windtree Therapeutics (WINT) United States $0.120B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Celyad SA (CYAD) Belgium $0.117B 0.00
Unum Therapeutics (COGT) United States $0.117B 0.00
Strongbridge Biopharma (SBBP) United States $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.112B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.112B 0.00
Orgenesis (ORGS) United States $0.111B 5.66
Gritstone Oncology (GRTS) United States $0.109B 0.00
Antibe Therapeutics (ATBPF) Canada $0.108B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.104B 0.00
AIT Therapeutics (XAIR) United States $0.103B 0.00
Oncobiologics (OTLK) United States $0.103B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
Palatin Technologies (PTN) United States $0.097B 0.00
Cyclerion Therapeutics (CYCN) United States $0.090B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
DiaMedica Therapeutics (DMAC) United States $0.081B 0.00
Stealth BioTherapeutics (MITO) United States $0.077B 74.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Appili Therapeutics (APLIF) Canada $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
AmpliPhi Biosciences (ARMP) United States $0.065B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.064B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Curis (CRIS) United States $0.064B 0.00
Edesa Biotech (EDSA) Canada $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.061B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.056B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.054B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Novogen (KZIA) Australia $0.043B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Vaccinex (VCNX) United States $0.039B 0.00
CollPlant Holdings (CLGN) Israel $0.039B 0.00
AnPac Bio-Medical Science (ANPC) China $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
OvaScience (MLND) United States $0.033B 0.00
Advaxis (ADXS) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00